ATC Group: N02CD05 Eptinezumab

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N02CD05 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N02 Analgesics
3 N02C Antimigraine preparations
4 N02CD Calcitonin gene-related peptide (CGRP) antagonists
5 N02CD05

Related product monographs

Title Information Source Document Type  
VYEPTI Concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
VYEPTI Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Austria (AT)

Estonia (EE)

France (FR)

Israel (IL)

Lithuania (LT)

Poland (PL)

Romania (RO)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.